Annual report pursuant to Section 13 and 15(d)

Securities Purchase Agreement (Details Narrative)

v3.5.0.2
Securities Purchase Agreement (Details Narrative)
1 Months Ended 12 Months Ended
Feb. 28, 2015
USD ($)
$ / shares
shares
Nov. 30, 2014
USD ($)
$ / shares
$ / unit
shares
Jul. 31, 2014
USD ($)
Apr. 30, 2016
USD ($)
$ / shares
shares
Apr. 30, 2015
USD ($)
$ / shares
$ / unit
shares
Securities Purchase Agreement (Textual) [Abstract]          
Gain on extinguishment of debt       $ 22,000
Restricted Stock | Chief Executive Officer          
Securities Purchase Agreement (Textual) [Abstract]          
Net proceeds from sale of stock and warrants $ 365,000        
Exercise price of warrants | $ / shares $ 7.50        
Risk-free interest rate 1.19%        
Expected volatility 90.50%        
Expected dividend rate 0.00%        
Expected term 5 years        
Restricted shares, issued and sold | shares 61,000        
Price per share | $ / shares $ 6.00        
Warrants issued | shares 105,333        
Series B Preferred Shares          
Securities Purchase Agreement (Textual) [Abstract]          
Preferred stock, shares converted | shares       4,125  
Common stock issued upon conversion of preferred stock | shares       27,500  
Adjustment to additional paid in capital upon redemption of preferred stock       $ 50,325  
Price per share | $ / shares       $ 12.20  
Private Placement | Series A Preferred Shares          
Securities Purchase Agreement (Textual) [Abstract]          
Common stock issued | shares       46,413  
Risk-free interest rate         1.19%
Expected volatility         90.50%
Expected dividend rate         0.00%
Strike price | $ / unit         7.50
Expected term         5 years
Private placement, description   On November 12, 2014, the Company completed a private placement of 600,000 shares of its Series A Preferred Stock (“Series A Stock”) together with Warrants to purchase shares of its common stock (“Preferred Warrant”) at a price of $5.00 per share, in accordance with the Series A Preferred Stock Purchase Agreement dated October 20, 2014 (the “Purchase Agreement”). At any time from November 17, 2014, the date of Closing, and prior to October 20, 2019 (the “Put/Call Exercise Period”), the investors may exercise a right to purchase and require the Company to sell up to an additional 700,000 shares of Series A Stock. If the investors have not exercised this right during the Put/Call Exercise Period, the Company may exercise a right to cause and require the investors to purchase up to an additional 700,000 shares of Series A Stock, for an aggregate purchase price of $3,500,000. Holders of the Series A Stock shall initially have the right to convert such shares of Series A Stock into the number of authorized but previously unissued shares of the Company’s common stock obtained by dividing the stated value of each share of Series A ($5.00) by $6.00. For each share of Series A Stock, the investors will receive 2.5 Preferred Warrants to purchase the Company’s common stock at an exercise price of $2.50 per share. The Preferred Warrants are exercisable immediately for a period of five years from the date of closing. The exercise price of the Preferred Warrants is subject to adjustments in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. The exercisability of the Preferred Warrants may be limited if upon exercise, the warrant holder or any of its affiliates would beneficially own more than 4.99% of the Company’s Common Stock.     On February 2, 2015, the Company completed a private placement of 26,600 shares of its Series A Stock together with Preferred Warrants to purchase shares of its common stock at a price of $5.00 per share, in accordance with the Purchase Agreement.
Private placement, conversion terms   Holders of the Series A Stock shall initially have the right to convert such shares of Series A Stock into the number of authorized but previously unissued shares of the Company's common stock obtained by dividing the stated value of each share of Series A ($5.00) by $2.00. For each share of Series A Stock, the investors will receive 2.5 Preferred Warrants to purchase the Company's common stock at an exercise price of $2.50 per share. The Preferred Warrants are exercisable immediately for a period of five years from the date of closing. The exercise price of the Preferred Warrants is subject to adjustments in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. The exercisability of the Preferred Warrants may be limited if upon exercise, the warrant holder or any of its affiliates would beneficially own more than 4.99% of the Company's Common Stock.      
Private placement preferred shares issued | shares   600,000   20,000 26,600
Proceeds from issuance of private placement   $ 2,700,000   $ 100,000 $ 133,000
Preferred stock, dividend rate, percentage   8.00%   8.00%  
Preferred stock, dividend rate, per share dollar amount | $ / shares   $ 0.40      
Preferred stock, shares converted | shares       123,300  
Common stock issued upon conversion of preferred stock | shares       205,500  
Reduction of preferred stock upon conversion, value       $ 365,000  
Adjustment to additional paid in capital upon redemption of preferred stock       365,000  
Preferred stock, dividends recorded       122,000 $ 111,000
Accumulated dividends, settled through issuance of stock       233,000  
Adjustment to additional paid in capital, settlement of dividends       $ 233,000  
Price per share | $ / shares   $ 5.00   $ 2.96 $ 5.00
Common stock issued for services | shares   60,833      
Warrants issued for services | shares   30,000      
Securities Purchase Agreement | Accredited Investors          
Securities Purchase Agreement (Textual) [Abstract]          
Shares of stock sold | shares       166,667  
Net proceeds from sale of stock and warrants       $ 500,000  
Price per share | $ / shares       $ 3.00  
Securities Purchase Agreement | Bridge Notes and Warrants          
Securities Purchase Agreement (Textual) [Abstract]          
Description of period for exercisability of warrants     The Bridge Warrants are exercisable for five years after the closing date of the Purchase Agreement, or July 15, 2019. For each $1,000 of principal amount of Bridge Notes, the holder received 1,200 Bridge Warrants, each exercisable for the purchase of one share of the Company’s common stock. Each holder is entitled to exercise one-third of all Bridge Warrants received at an exercise price of $9.00, one-third of all Bridge Warrants received at an exercise price of $10.50, and one-third of all Bridge Warrants received at an exercise price that is equal to the closing price on the closing date of the Purchase Agreement, $8.82.    
Exercise price of warrants | $ / shares   $ 2.00      
Bridge loan     $ 750,000    
Bridge loan, issuance date     Jul. 15, 2014    
Bridge loan, description     The Company issued $600,000 aggregate principal amount of the Bridge Notes to certain Institutional investors and $150,000 aggregate principal amount of the Bridge Notes to certain members of Management.    
Bridge loan, maturity date     Jul. 15, 2019    
Bridge loan, conversion description   The sale of shares of its Series A Stock resulted in the reduction of the conversion price of the Bridge Notes held by the institutional investors to $2.00 from $2.50 to equal the conversion price of the Series A Preferred Stock. The initial conversion price for Institutional Investors is $7.50 per share (which was subsequently reduced), and the initial conversion price for Management was equal to the closing price of the Company’s common stock on the closing date of the Purchase Agreement, $8.82.    
Bridge loan, interest rate     8.00%    
Preferred stock, shares issued | shares   600,000   55,083  
Preferred stock, shares issued, value       $ 649,967  
Extinguishment of debt       672,000  
Gain on extinguishment of debt       $ 22,033  
Risk-free interest rate       1.26%  
Expected volatility       100.00%  
Expected dividend rate       0.00%  
Expected term       5 years  
Discount on notes payable, warrants         $ 562,000
Beneficial conversion feature         188,000
Non-cash interest charge         $ 750,000
Bridge Note Holders of Warrants, number of warrants exchanged for Series B Preferred Stock | shares       255,000  
Series B Preferred Stock, issued as a result of exchange of warrants held by Bridge Note holders | shares       19,125  
Adjustment in additional paid in capital       $ 233,300  
Private Placement | Put/Call Option          
Securities Purchase Agreement (Textual) [Abstract]          
Risk-free interest rate   1.64%      
Expected volatility   93.00%      
Expected dividend rate   8.00%      
Expected term   5 years      
Private Placement | Warrant          
Securities Purchase Agreement (Textual) [Abstract]          
Risk-free interest rate   1.64%      
Expected volatility   93.00%      
Expected dividend rate   0.00%      
Strike price | $ / unit   7.50      
Expected term   5 years